Helicobacter pylori and Peptic Ulcer Disease

Scandinavian Journal of Gastroenterology

Volumn 31, Issue sup214, 1996, Pages 24-27

  Blum, A L ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Duodenal ulcer; eradication therapy; gastric ulcer; Helicobacter pylori; peptic ulcer disease

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; TETRACYCLINE; TINIDAZOLE;

CONFERENCE PAPER; DIARRHEA; DUODENUM ULCER; ERADICATION THERAPY; HELICOBACTER PYLORI; HUMAN; NAUSEA; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ULCER; ADULT; HELICOBACTER INFECTION; PATHOGENICITY; REVIEW;

ADULT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER;

EID: 0029864716     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365529609094511     Document Type: Article

References (24)

1. Sipponen P, Varis K, Fräki O, Korri U M, Seppälä K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990; 25: 966 – 73
2. Malfertheiner P, Halter F. Peptic ulcer pathogenesis. The year in Helicobacter pylori 1994, P Malfertheiner, F Mégraud, P Michetti, A Price. Current Science, London 1994; 30 – 4
3. Borody T J, George L L, Brandl S, Andrews P, Ostapowicz N, Hyland L, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991; 86: 1154 – 7
4. Bell G D, Powell K U. Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol 1993; 196 (28 Suppl) 7 – 11
5. Mohamed A H, Wilkinson J, Hunt R H. Duodenal ulcer recurrence after Helicobacter pylori (Hp) eradication: a meta-analysis. Gastroenterology 1994; 106: A142
6. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19 – 23
7. Blaser M J. Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol 1994; 205 (29 Suppl) 1 – 5
8. Crabtree J E, El-Omar E, Bugnoli M, Covacci A, Eyre D, Rappuoli R, et al. Serum CagA IgG antibodies in Helicobacter pylori positive healthy volunteers and patients with dyspeptic disease. Gut 1994; 35 (Suppl 2) S35
9. Borody T J, George L L, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N. Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication. Am J Gastroenterol 1992; 87: 1390 – 3
10. Cullen D JE, Hawkey G M, Humphries H, Cave R, Shepherd V, Logan R FA, et al. Role of non-steroidal anti-inflammatory drugs and Helicobacter pylori in bleeding peptic ulcer. Gastroenterology 1994; 106: A66
11. Hamlet A, Olbe L. Aspirin and Helicobacter pylori both block reflex pathways for inhibition of gastric acid secretion. Gastroenterology 1994; 106: A88
12. Reinbach D H, Cruickshank G, McColl K EL. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993; 34: 1344 – 7
13. Kawai K, Shirakawa K, Misaki F, Hayashi K, Watanabe Y. Natural history and epidemiologic studies of peptic ulcer disease in Japan. Gastroenterology 1989; 96 (Suppl) 581 – 5
14. Asaka M. Gastric mucosal infection with Helicobacter pylori. Gastrointest Res 1994; 2: 7 – 15
15. Aoyama N, Nakashima T. Eradication of Helicobacter pylori in gastric ulcer and relapse. Naika 1994; 73: 476 – 80
16. Labenz J, Borsch G. Change of the natural history of peptic ulcer disease after cure of Helicobacter pylori infection. A prospective long-term study. Am J Gastroenterol 1994; 89: 1376
17. Hirschl A M, Schütze K, Hentschel E, Gragosics B. Serological, microbiological and clinical results of a 43 months follow-up after successful eradication of H. pylori in duodenal ulcer patients. Am J Gastroenterol 1994; 89: 1374
18. Haruma K, Kawaguchi H, Kohmoto K, Tanaka S, Tsuda T, Takehara Y, et al. Reduced incidence of Helicobacter pylori infection in Japan during the last 10 years. Gastroenterology 1994; 106: A91
19. Kohmoto K, Haruma K, Kawaguchi H, Okamoto S, Uemura N, Teixeira C R, et al. Helicobacter pylori infection in young Japanese patients is a major risk factor for gastric carcinoma. Gastroenterology 1994; 106: A109
20. Heatley R V. Review article: the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1992; 6: 291 – 303
21. Axon A TR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 6: 131 – 7
22. Labenz J, Ruhl G H, Stolte M, Bertrams J, Borsch G. Efficacy of low-dose one-week triple therapy to cure H. pylori infection. Am J Gastroenterol 1994; 89: 1376
23. Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1 – 3
24. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65 – 9